(Q46436528)

22 December 2017

title

Challenges in the therapy of secondary hyperparathyroidism (English)

1 reference

22 December 2017

1 reference

Carla Wood

1

1 reference

22 December 2017

Esther A González

series ordinal

2

1 reference

22 December 2017

Kevin J Martin

series ordinal

3

1 reference

22 December 2017

publication date

1 February 2005

1 reference

22 December 2017

Therapeutic Apheresis and Dialysis

published in

1 reference

22 December 2017

volume

9

1 reference

22 December 2017

issue

1

1 reference

22 December 2017

page(s)

4-8

1 reference

22 December 2017

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1774-9987.2005.00208.X

Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1774-9987.2005.00208.X

Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1774-9987.2005.00208.X

The evolution of assays for parathyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1774-9987.2005.00208.X

Parathyroid hormone: new assays, new receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1774-9987.2005.00208.X

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1774-9987.2005.00208.X

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1774-9987.2005.00208.X

Effect of 22-oxacalcitriol on hyperparathyroidism of dialysis patients: results of a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1774-9987.2005.00208.X

In subtotally nephrectomized rats 22-oxacalcitriol suppresses parathyroid hormone with less risk of cardiovascular calcification or deterioration of residual renal function than 1,25(OH)2 vitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1774-9987.2005.00208.X

Parathyroid hormone (PTH), PTH-derived peptides, and new PTH assays in renal osteodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1774-9987.2005.00208.X

Calcimimetic agents and secondary hyperparathyroidism: treatment and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1774-9987.2005.00208.X

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1774-9987.2005.00208.X

Arterial calcifications and bone histomorphometry in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1774-9987.2005.00208.X

Achieving K/DOQI Laboratory Target Values for Bone and Mineral Metabolism: An Uphill Battle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1774-9987.2005.00208.X

10.1111/J.1774-9987.2005.00208.X

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017